Keywords
Last Name
Institution

LAYNE O GENTRY

TitleClinical Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address6624 Fannin St., Suite 1410
HOUSTON TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Tam VH, Hirsch EB, Lasco TM, Gentry LO, Palmer HR. Correlation of hospital carbapenem consumption and resistance trends in selected gram-negative bacteria. Ann Pharmacother. 2012 Jul-Aug; 46(7-8):1120-2. PMID: 22764323.
      View in: PubMed
    2. Palmer HR, Weston J, Gentry L, Salazar M, Putney K, Frost C, Tipton JA, Cottreau J, Tam VH, Garey KW. Improving patient care through implementation of an antimicrobial stewardship program. Am J Health Syst Pharm. 2011 Nov 15; 68(22):2170-4. PMID: 22058103.
      View in: PubMed
    3. Garey KW, Vo QP, Larocco MT, Gentry LO, Tam VH. Prevalence of type III secretion protein exoenzymes and antimicrobial susceptibility patterns from bloodstream isolates of patients with Pseudomonas aeruginosa bacteremia. J Chemother. 2008 Dec; 20(6):714-20. PMID: 19129069.
      View in: PubMed
    4. Garey KW, Dao-Tran TK, Jiang ZD, Price MP, Gentry LO, Dupont HL. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics. J Hosp Infect. 2008 Oct; 70(2):142-7. PMID: 18723249.
      View in: PubMed
    5. Garey KW, Amrutkar P, Dao-Tran TK, Frost CP, Chen H, Essien EJ, Gentry LO. Economic benefit of appropriate timing of vancomycin prophylaxis in patients undergoing cardiovascular surgery. Pharmacotherapy. 2008 Jun; 28(6):699-706. PMID: 18503397.
      View in: PubMed
    6. Tam VH, Gamez EA, Weston JS, Gerard LN, Larocco MT, Caeiro JP, Gentry LO, Garey KW. Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint. Clin Infect Dis. 2008 Mar 15; 46(6):862-7. PMID: 18279040.
      View in: PubMed
    7. Koo HL, Hamill RJ, Gentry LO. Disseminated histoplasmosis manifesting as a soft-tissue chest wall mass in a heart transplant recipient. Transpl Infect Dis. 2008 Oct; 10(5):351-3. PMID: 18194370.
      View in: PubMed
    8. Garey KW, Lai D, Dao-Tran TK, Gentry LO, Hwang LY, Davis BR. Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery. Antimicrob Agents Chemother. 2008 Feb; 52(2):446-51. PMID: 18025116; PMCID: PMC2224787.
    9. Tam VH, Schilling AN, LaRocco MT, Gentry LO, Lolans K, Quinn JP, Garey KW. Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa. Clin Microbiol Infect. 2007 Apr; 13(4):413-8. PMID: 17359326.
      View in: PubMed
    10. Price MF, Dao-Tran T, Garey KW, Graham G, Gentry LO, Dhungana L, Dupont HL. Epidemiology and incidence of Clostridium difficile-associated diarrhoea diagnosed upon admission to a university hospital. J Hosp Infect. 2007 Jan; 65(1):42-6. PMID: 17145108.
      View in: PubMed
    11. Amrutkar PP, Rege MD, Chen H, LaRocco MT, Gentry LO, Garey KW. Comparison of risk factors for candidemia versus bacteremia in hospitalized patients. Infection. 2006 Dec; 34(6):322-7. PMID: 17180586.
      View in: PubMed
    12. Garey KW, Kumar N, Dao T, Tam VH, Gentry LO. Risk factors for postoperative chest wound infections due to gram-negative bacteria in cardiac surgery patients. J Chemother. 2006 Aug; 18(4):402-8. PMID: 17024796.
      View in: PubMed
    13. Garey KW, Dao T, Chen H, Amrutkar P, Kumar N, Reiter M, Gentry LO. Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections. J Antimicrob Chemother. 2006 Sep; 58(3):645-50. PMID: 16807254.
      View in: PubMed
    14. Garey KW, Neuhauser MM, Bearden DT, Cannon JP, Lewis RE, Gentry LO, Kontoyiannis DP. Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study. Mycoses. 2006 May; 49(3):226-31. PMID: 16681815.
      View in: PubMed
    15. Tam VH, Adams S, LaRocco MT, Gerard LN, Gentry LO, Garey KW. An integrated pharmacoeconomic approach to antimicrobial formulary decision-making. Am J Health Syst Pharm. 2006 Apr 15; 63(8):735-9. PMID: 16595813.
      View in: PubMed
    16. Kachroo S, Dao T, Zabaneh F, Reiter M, Larocco MT, Gentry LO, Garey KW. Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant enterococcus colonization. Ann Pharmacother. 2006 Mar; 40(3):381-5. PMID: 16478809.
      View in: PubMed
    17. Lai T, Babb Y, Ning Q, Reyes L, Dao T, Lee VV, Mitchell L, Gentry LO, Reul RM, Ott DA. The transition from open to endoscopic saphenous vein harvesting and its clinical impact: The Texas Heart Institute experience. Tex Heart Inst J. 2006; 33(3):316-20. PMID: 17041688; PMCID: PMC1592263.
    18. Houston S, Gentry LO, Pruitt V, Dao T, Zabaneh F, Sabo J. Reducing the incidence of nosocomial pneumonia in cardiovascular surgery patients. Qual Manag Health Care. 2003 Jan-Mar; 12(1):28-41. PMID: 12593372.
      View in: PubMed
    19. Houston S, Hougland P, Anderson JJ, LaRocco M, Kennedy V, Gentry LO. Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care. 2002 Nov; 11(6):567-70. PMID: 12425407.
      View in: PubMed
    20. Price MF, Carlini M, Houston S, Gentry LO. Prevalence of nasal colonization with methicillin-resistant Staphylococcus aureus in selected patient populations. Infect Control Hosp Epidemiol. 2000 Sep; 21(9):603-5. PMID: 11001267.
      View in: PubMed
    21. Nichols RL, Smith JW, Gentry LO, Gezon J, Campbell T, Sokol P, Williams RR. Multicenter, randomized study comparing levofloxacin and ciprofloxacin for uncomplicated skin and skin structure infections. South Med J. 1997 Dec; 90(12):1193-200. PMID: 9404904.
      View in: PubMed
    22. Gentry LO. Management of osteomyelitis. Int J Antimicrob Agents. 1997 Jun; 9(1):37-42. PMID: 18611817.
      View in: PubMed
    23. Anaissie EJ, Darouiche RO, Abi-Said D, Uzun O, Mera J, Gentry LO, Williams T, Kontoyiannis DP, Karl CL, Bodey GP. Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature. Clin Infect Dis. 1996 Nov; 23(5):964-72. PMID: 8922787.
      View in: PubMed
    24. Sherertz RJ, Heard SO, Raad II, Gentry L, Bowton D, Scuderi P, Hu J, Carruth W, Satishchandra B, Pepe J, Mosenthal A, Burke T, Dupuis J. Gamma radiation-sterilized, triple-lumen catheters coated with a low concentration of chlorhexidine were not efficacious at preventing catheter infections in intensive care unit patients. Antimicrob Agents Chemother. 1996 Sep; 40(9):1995-7. PMID: 8878569; PMCID: PMC163461.
    25. Gentry LO, Nasser MM, Kielhofner M. Scopulariopsis endocarditis associated with Duran ring valvuloplasty. Tex Heart Inst J. 1995; 22(1):81-5. PMID: 7787475; PMCID: PMC325215.
    26. Price MF, LaRocco MT, Gentry LO. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother. 1994 Jun; 38(6):1422-4. PMID: 8092849; PMCID: PMC188224.
    27. Fang G, Keys TF, Gentry LO, Harris AA, Rivera N, Getz K, Fuchs PC, Gustafson M, Wong ES, Goetz A, Wagener MM, Yu VL. Prosthetic valve endocarditis resulting from nosocomial bacteremia. A prospective, multicenter study. Ann Intern Med. 1993 Oct 1; 119(7 Pt 1):560-7. PMID: 8363166.
      View in: PubMed
    28. Gentry LO. Cardiac transplantation and related infections. Semin Respir Infect. 1993 Sep; 8(3):199-206. PMID: 8016480.
      View in: PubMed
    29. Gentry LO. Diagnosis and management of the diabetic foot ulcer. J Antimicrob Chemother. 1993 Jul; 32 Suppl A:77-89. PMID: 8407701.
      View in: PubMed
    30. Gentry LO. Prescribing considerations in fluoroquinolone therapy. Pharmacotherapy. 1993 Mar-Apr; 13(2 Pt 2):39S-44S. PMID: 8474937.
      View in: PubMed
    31. Gentry LO, Rodriguez-Gomez G. Ofloxacin treatment of difficult infections of the skin and skin structure. Cutis. 1993 Jan; 51(1):55-8. PMID: 8419113.
      View in: PubMed
    32. Wiström J, Gentry LO, Palmgren AC, Price M, Nord CE, Ljungh A, Norrby SR. Ecological effects of short-term ciprofloxacin treatment of travellers' diarrhoea. J Antimicrob Chemother. 1992 Nov; 30(5):693-706. PMID: 1493985.
      View in: PubMed
    33. Gentry LO, Birovljev SM, Radovancevi? B, Cooley DA. Cefuroxime prophylaxis in cardiovascular surgery: clinical, microbiological, and ecological impact. Tex Heart Inst J. 1992; 19(1):21-5. PMID: 15227466; PMCID: PMC325013.
    34. Gentry LO. Therapy with newer oral beta-lactam and quinolone agents for infections of the skin and skin structures: a review. Clin Infect Dis. 1992 Jan; 14(1):285-97. PMID: 1571443.
      View in: PubMed
    35. Gentry LO, Rodriguez-Gomez G, Kohler RB, Khan FA, Rytel MW. Parenteral followed by oral ofloxacin for nosocomial pneumonia and community-acquired pneumonia requiring hospitalization. Am Rev Respir Dis. 1992 Jan; 145(1):31-5. PMID: 1731595.
      View in: PubMed
    36. Gentry LO, Lipsky B, Farber MO, Tucker B, Rodriguez-Gomez G. Oral ofloxacin therapy for lower respiratory tract infection. South Med J. 1992 Jan; 85(1):14-8. PMID: 1734527.
      View in: PubMed
    37. Gentry LO. Review of quinolones in the treatment of infections of the skin and skin structure. J Antimicrob Chemother. 1991 Dec; 28 Suppl C:97-110. PMID: 1787128.
      View in: PubMed
    38. Gentry LO, Rodriguez-Gomez G. Randomized comparison of cefepime and ceftazidime for treatment of skin, surgical wound, and complicated urinary tract infections in hospitalized subjects. Antimicrob Agents Chemother. 1991 Nov; 35(11):2371-4. PMID: 1804010; PMCID: PMC245387.
    39. Gentry LO. Bacterial resistance. Orthop Clin North Am. 1991 Jul; 22(3):379-88. PMID: 1649425.
      View in: PubMed
    40. Gentry LO, Rodriguez-Gomez G. Ofloxacin versus parenteral therapy for chronic osteomyelitis. Antimicrob Agents Chemother. 1991 Mar; 35(3):538-41. PMID: 2039205; PMCID: PMC245046.
    41. Gentry LO. Newer concepts in antimicrobial therapy. Clin Orthop Relat Res. 1990 Dec; (261):23-6. PMID: 2245550.
      View in: PubMed
    42. Gentry LO. Cefotaxime and prophylaxis. New approaches with a proven agent. Am J Med. 1990 Apr 9; 88(4A):32S-37S. PMID: 2183608.
      View in: PubMed
    43. Gentry LO. Future developments in nosocomial infections: the perspective in the United States. J Hosp Infect. 1990 Apr; 15 Suppl A:3-12. PMID: 1971642.
      View in: PubMed
    44. Gentry LO. Systemic antifungal agents. Tex Heart Inst J. 1990; 17(3):194-202. PMID: 15227171; PMCID: PMC324917.
    45. Gentry LO, Rodriguez GG. Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis. Antimicrob Agents Chemother. 1990 Jan; 34(1):40-3. PMID: 2183710; PMCID: PMC171517.
    46. Gentry LO, Rodriguez-Gomez G, Zeluff BJ, Khoshdel A, Price M. A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections. Am J Med. 1989 Dec 29; 87(6C):57S-60S. PMID: 2690621.
      View in: PubMed
    47. Gentry LO, Koshdel A. Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structure. Am J Med. 1989 Nov 30; 87(5A):132S-135S. PMID: 2686413.
      View in: PubMed
    48. Soroko T, Morrison S, Khosdal A, Isham BD, Gargantiel A, Gentry L, Minnefor A. Ciprofloxacin treatment of sternal wound infections following open heart surgery. Am J Med. 1989 Nov 30; 87(5A):240S-242S. PMID: 2589371.
      View in: PubMed
    49. Gentry LO, Ramirez-Ronda CH, Rodriguez-Noriega E, Thadepalli H, del Rosal PL, Ramirez C. Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial. Arch Intern Med. 1989 Nov; 149(11):2579-83. PMID: 2684078.
      View in: PubMed
    50. Gentry LO, Khoshdel A. New approaches to the diagnosis and treatment of infective endocarditis: review of 100 consecutive cases. Tex Heart Inst J. 1989; 16(4):250-7. PMID: 15227377; PMCID: PMC326529.
    51. Gentry LO, Zeluff BJ, Cooley DA. Antibiotic prophylaxis in open-heart surgery: a comparison of cefamandole, cefuroxime, and cefazolin. Ann Thorac Surg. 1988 Aug; 46(2):167-71. PMID: 3401076.
      View in: PubMed
    52. Gentry LO. Osteomyelitis: options for diagnosis and management. J Antimicrob Chemother. 1988 Apr; 21 Suppl C:115-31. PMID: 3290180.
      View in: PubMed
    53. Poindexter AN, Ritter M, Faro S, Castellano MA, Gentry LO, Ismail M, Knuppel RA, Kreutner AK, Lamb EJ, LeFrock JL, et al. Results of noncomparative studies of cefotetan in the treatment of obstetric and gynecologic infections. Am J Obstet Gynecol. 1988 Mar; 158(3 Pt 2):717-21. PMID: 3162652.
      View in: PubMed
    54. Zeluff BJ, Lowe P, Koornhof HJ, Gentry LO. Evaluation of roxithromycin (RU-965) versus cephradine in pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis. 1988 Feb; 7(1):69-71. PMID: 3132383.
      View in: PubMed
    55. Gentry LO, Zeluff BJ. Nosocomial and other difficult infections in the immunocompromised cardiac transplant patient. J Hosp Infect. 1988 Feb; 11 Suppl A:21-8. PMID: 2896709.
      View in: PubMed
    56. Zeluff BJ, Gentry LO. Cefamandole prophylaxis for cardiovascular surgery: a dosage comparison. Tex Heart Inst J. 1987 Dec; 14(4):374-81. PMID: 15227293; PMCID: PMC324761.
    57. Gentry LO. Roxithromycin, a new macrolide antibiotic, in the treatment of infections in the lower respiratory tract: an overview. J Antimicrob Chemother. 1987 Nov; 20 Suppl B:145-52. PMID: 3323166.
      View in: PubMed
    58. Zeluff B, Gentry LO. Management of infection in the post-cardiac-transplant patient. Tex Heart Inst J. 1987 Sep; 14(3):247-51. PMID: 15227306; PMCID: PMC324732.
    59. Gentry LO. Cephalosporins in urinary tract infection. Drugs. 1987; 34 Suppl 2:154-63. PMID: 3319499.
      View in: PubMed
    60. Feliciano DV, Gentry LO, Bitondo CG, Burch JM, Mattox KL, Cruse PA, Jordan GL. Single agent cephalosporin prophylaxis for penetrating abdominal trauma. Results and comment on the emergence of the enterococcus. Am J Surg. 1986 Dec; 152(6):674-81. PMID: 3789294.
      View in: PubMed
    61. Gentry LO. Antimicrobial activity, pharmacokinetics, therapeutic indications and adverse reactions of ceftazidime. Pharmacotherapy. 1985 Sep-Oct; 5(5):254-67. PMID: 3906585.
      View in: PubMed
    62. Radovancevic B, Frazier OH, Gentry LO, Okereke OU, Cooley DA. Successful treatment of invasive aspergillosis in a heart transplant patient. Tex Heart Inst J. 1985 Sep; 12(3):233-7. PMID: 15227009; PMCID: PMC341861.
    63. Gentry LO, Feliciano DV, Lea AS, Short HD, Mattox KL, Jordan GL. Perioperative antibiotic therapy for penetrating injuries of the abdomen. Ann Surg. 1984 Nov; 200(5):561-6. PMID: 6385878; PMCID: PMC1250536.
    64. Gentry LO, Douthit MB, Childs SJ, Madsen PO. A random comparative trial of 0.25, 0.5 and 1.0 g ceftazidime twice daily in urinary tract infection. J Antimicrob Chemother. 1983 Jul; 12 Suppl A:53-7. PMID: 6352655.
      View in: PubMed
    65. Lea AS, Sudan AW, Gould PL, Gentry LO. A comparative trial of ceftizoxime versus cefamandole in the treatment of acute urinary tract infections. J Antimicrob Chemother. 1982 Nov; 10 Suppl C:261-3. PMID: 6296018.
      View in: PubMed
    66. Lea AS, Feliciano DV, Gentry LO. Intra-abdominal infections-an update. J Antimicrob Chemother. 1982 Jan; 9 Suppl A:107-13. PMID: 7076608.
      View in: PubMed
    67. Wilkinson LD, Gentry LO. In-vitro comparison of ceftazidime and nine other antimicrobial agents against hospital strains of Gram-negative bacteria. J Antimicrob Chemother. 1981 Sep; 8 Suppl B:53-6. PMID: 19802969.
      View in: PubMed
    68. Jemsek JG, Martin RR, Greenberg SB, Gentry LO. Antimicrobial susceptibility testing of Haemophilus parainfluenzae by a kinetic killing-curve method. J Infect Dis. 1980 Mar; 141(3):310-6. PMID: 6444977.
      View in: PubMed
    69. Short HD, Gentry LO, Sessoms S. Cefamandole nafate therapy in the treatment of acute urinary tract infections. J Antimicrob Chemother. 1976 Dec; 2(4):345-50. PMID: 802125.
      View in: PubMed
    GENTRY's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _